RA Remission Claim May Be Granted Despite Relapse - FDA Guidance
Rheumatoid arthritis remission indications may be approved even if patients relapse after six months or more of remission, FDA's Feb. 17 final guidance on RA treatments states.
Rheumatoid arthritis remission indications may be approved even if patients relapse after six months or more of remission, FDA's Feb. 17 final guidance on RA treatments states.